Product image of Minodiab (Glipizide) supplied by GNH India

Minodiab

Active Ingredient:
Glipizide
Origin:
EU

Minodiab (Glipizide)

Glipizide, the active ingredient in Minodiab, is a sulfonylurea presented as an oral tablet for oral use. It treats type 2 diabetes mellitus in adult patients by enhancing insulin secretion.

GNH India supplies Minodiab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Pfizer Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glipizide is a sulfonylurea used to manage hyperglycemia in type 2 diabetes.

  • Type 2 diabetes mellitus: improves glycemic control by increasing endogenous insulin release.
  • Adjunct to diet and exercise: helps achieve target fasting and post‑prandial glucose levels.
  • Hyperglycemia: reduces elevated blood glucose concentrations when oral agents are required.

How It Works

  • Glipizide binds to the sulfonylurea receptor subunit of the ATP‑sensitive potassium channel on pancreatic beta cells. This binding closes the channel, leading to cell depolarisation, calcium influx and subsequent exocytosis of insulin, thereby increasing peripheral glucose uptake and lowering blood glucose levels.

Side Effects

Glipizide may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects

  • Hypoglycemia: episodes of low blood sugar, especially if meals are missed.
  • Weight gain: modest increase in body weight due to enhanced insulin activity.
  • Nausea: mild gastrointestinal discomfort.

Serious or Rare Side Effects

  • Severe hypoglycemia: prolonged or severe low blood sugar requiring medical attention.
  • Allergic reactions: rash, Stevens‑Johnson syndrome, or other severe skin manifestations.
  • Blood dyscrasias: leukopenia, thrombocytopenia, or other hematologic abnormalities.

Precautions & Warnings

When prescribing or dispensing Minodiab, several safety considerations are recommended.

  • Blood glucose monitoring: check levels regularly to avoid hypoglycemia.
  • Renal impairment: dose may need adjustment in reduced kidney function.
  • Elderly patients: start with a lower dose and monitor closely.
  • Hepatic disease: use with caution in liver dysfunction.
  • Allergy: discontinue if hypersensitivity reactions occur.
  • Store at room temperature: keep in original container, protect from moisture and heat.

Avoid Interactions

Glipizide can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid)

  • Concurrent sulfonylureas or meglitinides: additive risk of hypoglycemia.
  • Strong CYP2C9 inhibitors (e.g., fluconazole, amiodarone): increase glipizide plasma levels.
  • High‑dose aspirin: may potentiate hypoglycemic effect.

Moderate Interactions (Monitor Closely)

  • Beta‑blockers: may mask symptoms of hypoglycemia.
  • Thiazide diuretics: can enhance hyperglycemic effect of glipizide.
  • Oral contraceptives: may alter glipizide metabolism.

Frequently Asked Questions

Minodiab contains glipizide, a sulfonylurea indicated for the treatment of type 2 diabetes mellitus. It is used to improve blood‑sugar control when diet, exercise, and other non‑pharmacologic measures are insufficient.

Glipizide stimulates pancreatic beta‑cells by binding to the sulfonylurea receptor on ATP‑sensitive potassium channels. This closes the channel, causing cell depolarisation, calcium influx and increased insulin release, which lowers circulating glucose.

The dose of Minodiab is individualized. A qualified prescriber determines the starting dose, titration schedule and maximum daily amount based on the patient’s clinical condition, renal function and response to therapy.

Safety of glipizide in pregnancy and lactation has not been established. It is generally avoided unless the potential benefit outweighs the risk, and alternative agents with more data are preferred.

Enquiries are submitted via the product page on gnhindia.com. Provide the required quantity; GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then replies with pricing, availability, shipping details and any necessary import documentation.

Compared with metformin, another first‑line oral antidiabetic, glipizide acts by increasing insulin secretion rather than reducing hepatic glucose production. Glipizide may cause hypoglycemia and weight gain, whereas metformin is weight‑neutral and has a lower hypoglycemia risk.

Store Minodiab at room temperature, below 25 °C, in the original blister or bottle. Protect it from moisture, direct sunlight and excessive heat to maintain tablet integrity.

Minodiab is taken orally, usually once daily with breakfast or the first main meal. It can be swallowed whole with a glass of water; food may help reduce the risk of hypoglycemia.

The most serious risks include severe hypoglycemia, allergic skin reactions such as Stevens‑Johnson syndrome, and hematologic abnormalities like leukopenia or thrombocytopenia. Prompt medical attention is required if any of these occur.

Minodiab should not be used in patients with type 1 diabetes, diabetic ketoacidosis, known hypersensitivity to sulfonylureas, or severe renal or hepatic impairment unless specifically directed by a specialist.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Glipizide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT